Johnson & Johnson (NYSE: JNJ)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-19 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.610 | 2.670 | 0.0600 | ||||
REV | 23.670B | 23.426B | -244.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Johnson & Johnson (NYSE: JNJ) through any online brokerage.
Other companies in Johnson & Johnson’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS), Roivant Sciences (NASDAQ:ROIV) and Pfizer (NYSE:PFE).
The latest price target for Johnson & Johnson (NYSE: JNJ) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 205.00 expecting JNJ to rise to within 12 months (a possible 14.22% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Johnson & Johnson (NYSE: JNJ) is $179.48 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $1.13 per share of Class A Common Stock. The quarterly cash dividend was payable on June 7, 2022 to stockholders of record on May 23, 2022.
Johnson & Johnson’s Q2 earnings are confirmed for Tuesday, July 19, 2022.
There is no upcoming split for Johnson & Johnson.
Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.